Shirasawa N, Yamanouchi H
Department of Anatomy, Wakayama Medical College, Japan.
J Anat. 1999 May;194 ( Pt 4)(Pt 4):567-77. doi: 10.1046/j.1469-7580.1999.19440567.x.
Glutamine synthetase (GS) is a glucocorticoid-inducible enzyme that has a key role for glutamate metabolism in the central and peripheral nervous system. In this study GS activity was measured and the amount of immunoreactive GS (ir-GS) cells in the rat anterior pituitary gland was quantified as a function of age. In addition, the effects of GS inhibitors, glucocorticoid administration, and adrenalectomy on GS activity were examined. Some of the ir-GS cells were also immunoreactive for S100 protein (ir-S100) which is a known marker for folliculostellate cells (FS) in the anterior pituitary. FS cells expressing GS were first detected in 3-d-old rats, and this cell population, expressed as the immunostained cell area divided by a standard unit area, increased as a function of age. The percentages of FS cells also expressing GS were 0.2, 6.4, 25 and 74% at 3 d, 30 d, 60 d and 2 y of age, respectively. GS enzyme activity also increased in parallel with the increase of ir-GS cell population maturation. The subcutaneous injection of methionine sulphoximine, a GS and gamma-glutamylcysteine synthetase inhibitor, reduced pituitary GS activity by 83%, but increased the population of ir-GS cells 3.5-fold in 30-d-old rats. Buthionine sulphoximine, a specific inhibitor of y-glutamylcysteine synthetase, had little effect on GS activity or the ir-GS cell population. Neither methionine sulphoximine nor buthionine sulphoximine changed the population of ir-S100 protein cells (FS cells). Dexamethasone and hydrocortisone increased the population of ir-GS cells by 3.1 and 4.2-fold, respectively, within 12 h after administration. A significant increase of GS activity due to the injection of glucocorticoids was observed in the anterior pituitary, but not in the brain, retina or liver of immature rats. Adrenalectomy did not cause decrease of pituitary GS activity, and dexamethasone administration increased GS activity in both adrenalectomised and intact rats. In the monolayer culture of anterior pituitary cells, glucocorticoids increased GS activity by x 1.5, and methionine sulphoximine reduced the activity by over 94%. These results demonstrate that GS in folliculostellate cells is a glucocorticoid-inducible enzyme in vivo and in vitro, and that the age-dependent increase of GS activity is independent of endogenous adrenal glucocorticoids.
谷氨酰胺合成酶(GS)是一种糖皮质激素诱导型酶,在中枢和外周神经系统的谷氨酸代谢中起关键作用。在本研究中,测量了大鼠垂体前叶中GS的活性,并对免疫反应性GS(ir-GS)细胞的数量随年龄变化进行了定量分析。此外,还研究了GS抑制剂、糖皮质激素给药及肾上腺切除术对GS活性的影响。部分ir-GS细胞也对S100蛋白呈免疫反应(ir-S100),S100蛋白是垂体前叶中卵泡星状细胞(FS)的已知标志物。表达GS的FS细胞最早在3日龄大鼠中被检测到,该细胞群体以免疫染色细胞面积除以标准单位面积表示,随年龄增长而增加。在3日龄、30日龄、60日龄和2岁时,同时表达GS的FS细胞百分比分别为0.2%、6.4%、25%和74%。GS酶活性也随着ir-GS细胞群体成熟度的增加而平行升高。皮下注射甲硫氨酸亚砜亚胺(一种GS和γ-谷氨酰半胱氨酸合成酶抑制剂)可使30日龄大鼠垂体GS活性降低83%,但使ir-GS细胞数量增加3.5倍。丁硫氨酸亚砜亚胺(γ-谷氨酰半胱氨酸合成酶的特异性抑制剂)对GS活性或ir-GS细胞群体影响很小。甲硫氨酸亚砜亚胺和丁硫氨酸亚砜亚胺均未改变ir-S100蛋白细胞(FS细胞)的数量。地塞米松和氢化可的松在给药后12小时内分别使ir-GS细胞数量增加3.1倍和4.2倍。在未成熟大鼠的垂体前叶中观察到因注射糖皮质激素导致GS活性显著增加,但在脑、视网膜或肝脏中未观察到。肾上腺切除术未导致垂体GS活性降低,地塞米松给药使肾上腺切除大鼠和完整大鼠的GS活性均增加。在垂体前叶细胞的单层培养中,糖皮质激素使GS活性增加1.5倍,甲硫氨酸亚砜亚胺使活性降低超过94%。这些结果表明,卵泡星状细胞中的GS在体内和体外均为糖皮质激素诱导型酶,且GS活性随年龄的增加与内源性肾上腺糖皮质激素无关。